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Ryanodine receptors (RyRs) and inositol 1,4,5-trisphosphate receptors (IP3Rs) are calcium (Ca2+) 
release channels on the endo/sarcoplasmic reticulum (ER/SR). Here we summarize the latest 
advances in the field, describing the recently discovered mechanistic roles of intracellular Ca2+ 
release channels in the regulation of mitochondrial fitness and endothelial function, providing novel 
therapeutic options for the treatment of heart failure, hypertension, and diabetes mellitus.  
Keywords: excitation-contraction coupling, heart failure, hypertension, diabetes mellitus, 
intracellular Ca2+ release channels, IP3R, RyR.  
  
 





The ryanodine receptor (RyR) and the inositol 1,4,5-trisphosphate receptor (IP3R) are the main 
intracellular calcium (Ca2+) release channels, located on the sarco/endoplasmic reticulum (SR/ER) of 
most cell types. Herein, we provide an updated and systematic overview of their functional roles in 
health and disease. 
The endo/sarcoplasmic reticulum (ER/SR) of most cell types is the location of two types of 
intracellular Ca2+ release channels: the ryanodine receptors (RyRs) and the inositol 1,4,5-
trisphosphate receptors (IP3Rs) (Go et al., 1995). There is ~40% homology between RyR and lP3R in 
the putative transmembrane regions, indicating that these two channels evolved from a common 
ancestral channel. Although structurally related, RyRs and IP3Rs have distinct physiologic and 
pharmacologic profiles. 
RyRs vs IP3R 
RyR is a member of the same gene family as IP3R, but has evolved specialized functions required for 
excitation-contraction coupling (E-C coupling) in striated muscles. RyR was initially purified using the 
high affinity plant alkaloid ryanodine: when bound to RyR at low concentrations ryanodine locks the 
channel in a half open state, resulting in depletion of Ca2+ from the SR and subsequent interruption 
of E-C coupling. Extracts from the Ryania plant family were used by natives of South and Central 
America as poison for arrowheads as release of SR Ca2+ via the stably open RyRs causes tetany and 
  
 




RyR is normally closed at low cytosolic [Ca2+] (~100–200 nM); at submicromolar cytosolic [Ca2+] Ca2+ 
binds to high-affinity binding sites on RyR increasing the open probability (Po) of the channel. 
Channel activity is maximal at cytosolic [Ca2++ ~10 μM while elevating cytosolic *Ca2+] beyond this 
point leads to a reduction in Po (Bezprozvanny et al., 1993). A modulation of RyR gating by luminal 
Ca2+ has also been proposed (Chen et al., 2014). RyR is a homotetramer comprised of four 565 kDa 
monomers, of approximately 5000 amino acids each (Zalk et al., 2015). There are three subtypes of 
RyRs in mammalian tissues: RyR1 (Marks et al., 1989) and RyR2 (Brillantes et al., 1992) are required 
for E-C coupling in skeletal and cardiac muscle, respectively, and are also expressed in non-muscle 
tissues and regulated during development and by hormones (Fitzgerald et al., 1994; Maki et al., 
1996; Rosemblit et al., 1999) (Brillantes et al., 1994b); RyR3 was originally identified in the brain but 
is widely expressed in non-neuronal tissues (McPherson & Campbell, 1990; McPherson et al., 1991; 
Hakamata et al., 1992; Kuwajima et al., 1992). RyRs are macromolecular complexes (Marks et al., 
2002a) and enzymes are specifically targeted to the channels’ cytoplasmic domain to regulate its 
gating and activity and stress induced remodeling of the complex contributes to disorders including 
muscular dystrophy, heart failure, cardiac arrhythmias, and cognitive dysfunction (Marx et al., 2000; 
Marx et al., 2001; Reiken et al., 2003; Lehnart et al., 2005; Wehrens et al., 2006; Bellinger et al., 
2008; Lehnart et al., 2008; Bellinger et al., 2009; Liu et al., 2009; Fauconnier et al., 2010; Shan et al., 
2010a; Shan et al., 2010b; Andersson et al., 2011; Liu et al., 2012; Santulli et al., 2015b; Zalk et al., 
2015; des Georges et al., 2016; Ferrantini et al., 2016).  
IP3R channels are homo or heterotetramers composed of four subunits (approximately 300,000 Da 
each). Three forms of IP3Rs (types 1, 2 and 3) have been described (Nakagawa et al., 1991). Virtually 
all cell types have at least one form of IP3R, and many express all three types. IP3R2 is the 
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predominant isoform in contractile myocardial cells and in the sinoatrial node (Verma et al., 1992), 
whereas IP3R1 is the more abundant in other cell types, including endothelial cells (EC) and Purkinje 
fibers (Gorza et al., 1993). IP3R function is regulated by a classic second messenger cellular signaling 
pathway mediated by inositol 1,4,5-trisphosphate (IP3), produced primarily by phospholipase C (PLC) 
metabolism of phosphoinositol-4,5-bisphosphate (PIP2) in response to the stimulation of G-protein-
coupled receptors (GPCRs). IP3Rs are also macromolecular signaling complexes that mediate 
phosphorylation by receptor tyrosine kinases, non-receptor tyrosine kinases, for instance protein 
kinase A (PKA), and are regulated during physiological and pathophysiological states (Marks et al., 
1990; Marks, 1992; Moschella & Marks, 1993; Harnick et al., 1995; Jayaraman et al., 1995; Moschella 
et al., 1995; Jayaraman et al., 1996; Gutstein & Marks, 1997; Jayaraman & Marks, 1997; Marks, 
1997; Kobrinsky et al., 1999; Jayaraman & Marks, 2000; DeSouza et al., 2002; Santulli & Marks, 2015; 
Yuan et al., 2016). 
 
Recent structural insights  
In 2015, the high-resolution structures of these intracellular Ca2+ release channels were determined 
using cryogenic electron microscopy (Fan et al., 2015; Zalk et al., 2015). RyR1 adopts a four-fold 
symmetric mushroom-like superstructure, with six transmembrane helices (S1-S6) per protomer 
surrounding the central pore (Zalk et al., 2015). Each protomer is built around an extended scaffold 
of α-solenoid repeats which include an amino-terminal, a bridging, and a core solenoid. At the 
extreme outer corners of the tetramer there are three SPRY domains (so named because they were 
identified in both Dictyostelium discoideum tyrosine kinase Spore lysis A and the mammalian RyR) 
and two pairs of RyR repeats, RY12 and RY34, the latter comprising a regulatory PKA 
phosphorylation site (Santulli & Marks, 2015). Glycine residues in the pore-lining helices may 
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operate as “hinges” to facilitate the orientation of the cytoplasmic extension of S6 in order to 
modulate the aperture of the channel. Interestingly, Gly4934 is conserved in all RyR isoforms and in 
the IP3R (Santulli & Marks, 2015; Zalk et al., 2015; des Georges et al., 2016). 
The structure of the IP3R monomer comprises a ligand-binding pocket located near the N-terminus, 
a central cytosolic regulatory domain, and a pore region containing six transmembrane helices 
forming the Ca2+ channel region located at the C-terminus. The central Ca2+-conduction pathway is 
similar to other ion channels, the cytosolic C-termini are uniquely arranged in a left-handed α-helical 
bundle, directly interacting with the N-terminal domains of adjacent subunits (Fan et al., 2015). 
RyR and IP3R forms macromolecular signaling complexes 
Multiple proteins bind to RyR channels modulating their function. The Ca2+ stabilizing proteins 
calstabin1 (calcium channel stabilizing binding protein, previously known as FKBP12) and calstabin2 
(FKBP12.6) are peptidyl-propyl-cis-trans isomerases that bind via amphiphilic β-sheet structures to 
RyR1 and RyR2, respectively, such that one calstabin protein is bound to each RyR monomer 
resulting in a stoichiometry of calstabin:RyR of 4:1 (Brillantes et al., 1994a; Marx et al., 2000). 
Calstabins stabilize the closed state of RyR channels and prevent pathological intracellular Ca2+ leak 
(Jayaraman et al., 1992; Timerman et al., 1993; Brillantes et al., 1994a; Ondrias et al., 1998; Marx et 
al., 2000; Gaburjakova et al., 2001; Lehnart et al., 2006; Yuan et al., 2014; Santulli et al., 2015a). 
Calstabin1 and calstabin2 differ at only 18 out of 108 residues. We identified the calstabin-binding 
loop as part of the amino-terminal subdomain of the bridging solenoid (Zalk et al., 2015). Calstabin 
binding may rigidify the interface between such a subdomain with SPRY1-2, thereby stabilizing the 
connection with the cytosolic regulatory domains and eventually altering the relative orientation of 
these domains (Santulli & Marks, 2015; Zalk et al., 2015).  
We have shown that pharmacological stabilization of the RyR closed state using a novel class of small 
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molecules called Rycals (Andersson & Marks, 2010) prevents stress-induced dissociation of calstabin 
from RyR (Marx et al., 2000; Shan et al., 2010a; Shan et al., 2010b) and prevents intracellular Ca2+ 
leak improving leak-related disorders, including heart failure (HF) (Marx et al., 2000; Wehrens et al., 
2005), arrhythmias (Lehnart et al., 2006; Xie et al., 2015), muscular dystrophy (Andersson et al., 
2012), stress-induced cognitive dysfunction (Liu et al., 2012), diabetes mellitus (Santulli et al., 
2015a), and age-related loss of muscle function (Andersson et al., 2011), providing a promising 
potential therapeutic option for these disorders. Indeed, Rycals are in clinical development for 
treatment of muscular dystrophies.  
Highly conserved leucine-isoleucine zipper motifs in RyR2 form binding sites for adaptor proteins 
that mediate binding of other proteins, including kinases (e.g. PKA) (Marx et al., 2000), 
phosphodiesterases (PDE4D3) (Lehnart et al., 2005; Santulli et al., 2015b) and phosphatases (e.g. 
PP1 and PP2A) (Marx et al., 2000). Specifically, the adaptor protein mAKAP mediates the binding of 
PKA and phosphodiesterase PDE43, whereas PP1 and PP2A are targeted to RyR2 via spinophilin and 
PR130, respectively (Marx et al., 2001; Lehnart et al., 2005). These enzymes regulate the 
phosphorylation-dephosphorylation of RyR1 at RyR1-S2844 (Andersson et al., 2011) and RyR2 at 
RyR2-Ser2808 (Marx et al., 2000) in response to stress. RyR2 is also phosphorylated by 
Ca2+/calmodulin-dependent serine/threonine kinase δ (CaMKIIδ) at RyR2-Ser2814 (Kushnir et al., 
2010). Furthernore, RyRs are finely regulated by oxidation and nitrosylation. Other modulatory 
proteins that complex with RyR include calmodulin, calsequestrin, sorcin, triadin, Bcl-2, histidine-rich 
Ca2+ binding protein, junctin, and homer (Santulli & Marks, 2015). 
Similarly, regulatory proteins have been shown to bind to IP3R regulating its function, including Bcl-
2, ankyrin, caldendrin, calmodulin, homer, carbonic anhydrase-related protein (CARP), and IP3R-
binding protein released by IP3 (IRBIT) (Santulli & Marks, 2015). Furthermore, the IP3R structure 
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undergoes significant conformational changes under influence of Ca2+ (Hamada et al., 2002). We 
have demonstrated that PKA and phosphatases PP1 and PP2A are active components of the IP3R1 
macromolecular complex (DeSouza et al., 2002). Other kinases, including CaMKII, Fyn, PKG, and PKC 
have been also shown to phosphorylate IP3R (Santulli & Marks, 2015).  
E-C coupling in skeletal and cardiac muscle 
Luigi Galvani established the relationship between electrical signaling and mechanical contraction 
conducting experiments using frog legs (Galvani, 1791). In 1883 Sidney Ringer discovered that Ca2+ is 
a key component of muscle contractility (Ringer, 1883) and his observations were confirmed in 1913 
by George Mines, who demonstrated that Ca
2+
 is responsible for linking excitation and contraction 
(Mines, 1913).  
E-C coupling is similar in skeletal and cardiac muscle but there are important differences (Figures 1 
and 2). While in the heart a depolarizing Na+ current activates Ca2+ influx via the L-type Ca2+ channel 
(LCC, Cav1.2), which in turn activates the RyR2 isoform via Ca
2+-induced Ca2+ release (Fabiato & 
Fabiato, 1975), the depolarization of skeletal myocytes involves a protein-protein interaction across 
the junctional cleft between the dihydropyridine receptor (Cav1.1) located in specialized 
invaginations of the sarcolemma (transverse tubules) and RyR1 on the SR membrane (terminal 
cisternae), leading to Ca2+ release. Hence, Cav1.1 acts as a marionettist on RyR1, leading to Ca
2+ 
release from the SR via protein-protein interaction. The rise in cytoplasmic [Ca2+] is critical for 
activation of actin-myosin cross-bridging, shortening of the sarcomere and causing muscle 
contraction. 
 
RyR1 dysfunction has been described in both inherited and acquired skeletal muscle disorders, 
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including malignant hyperthermia (MH), age-related loss of muscle function (sarcopenia), central 
core disease (CCD) and muscular dystrophies (Bellinger et al., 2009; Andersson et al., 2011; 
Umanskaya et al., 2014; Santulli & Marks, 2015; Matecki et al., 2016). 
 
In contrast to RyRs, there is no strong experimental evidence for a significant functional role for IP3R-
mediated Ca2+ release in adult muscle fibers. We have previously reported that immunodetectable 
IP3Rs and specific [
3H]IP3–binding sites are expressed in slow oxidative (type I) and fast oxidative 
glycolytic (type IIA) fibers (Moschella et al., 1995). The expression of the three isoforms has been 
investigated in adult murine skeletal muscle, revealing that IP3R1 is absent in slow-type muscle 
fibers and is preferentially expressed in fast, mixed metabolism (type IIX) fibers whereas IP3R2 and 
IP3R3 are ubiquitously expressed (Casas et al., 2010).  
 
In the heart, RyR2 channels play a major role both in contraction and arrhythmogenesis (Lehnart et 
al., 2005; Xie et al., 2015). RyR2 is responsible for Ca2+ release from the SR, where it is stored at high 
concentration (millimolar range), thereby raising the cytosolic [Ca2+] about ten-fold (from ~100 nM 
to ~1 μM) with each heartbeat in order to activate cardiac contraction. Dysfunctional RyR2 channels 
have been reported in HF (Marx et al., 2000; Santulli et al., 2015b) and in atrial and ventricular 
arrhythmias, particularly associated with increased catecholaminergic stimulation (Lehnart et al., 
2006; Xie et al., 2013). The dysorganization of T-tubules (“orphaned RyR2”) also plays a role in the 
altered Ca-handling observed in HF (Song et al., 2006; Ferrantini et al., 2013; Ferrantini et al., 2014). 
Abnormal intracellular Ca2+ handling represents a major cause of decreased muscle contraction and 
defective relaxation in HF, as confirmed by reports of reduced Ca2+ transient amplitude, increased 
Ca2+ transient duration, prolonged Ca2+ transient decay time, and decreased SR Ca2+ load, leading to 
  
 
This article is protected by copyright. All rights reserved. 
  
10 
impaired contractility (Marx et al., 2000).  
 
On the other hand, the functional role of IP3Rs in cardiomyocytes is controversial. In cardiac 
myocytes, IP3R mRNA levels are ~50-fold lower than RyR2 (Moschella & Marks, 1993). Thus, the 
relative amount of IP3Rs is low and the kinetics of Ca2+ release from IP3Rs is too slow compared with 
RyRs to contribute to the Ca2+ transient during E-C coupling. Besides, Ca2+ flux via RyR channels has 
been shown to be markedly larger than the flux through IP3R (Zima & Blatter, 2004).  
Whereas mutations in RyR2 have been linked to at least two forms of sudden cardiac death 
(catecholaminergic polymorphic ventricular tachycardia, CPVT and arrhythmogenic right ventricular 
dysplasia type 2, ARVD2) (Marks et al., 2002b; Lehnart et al., 2006; Santulli, 2012 ), mutations in 
IP3Rs have not been linked to cardiac disorders: a whole-genome analysis identified the presence of 
a homozygous missense mutation in the gene encoding for IP3R2, in patients affected by anhidrosis 
(Klar et al., 2014).  
 
Since intracellular Ca2+ release from RyR2 dominates in the heart, the study of IP3-induced 
intracellular Ca2+ release in cardiomyocytes has been difficult. Evaluation of intracellular Ca2+ release 
in response to IP3 in cardiac preparations revealed Ca2+ responses that are of much lower magnitude 
than those seen with activators of RyR (Kentish et al., 1990). Similarly, direct generation of IP3 in 
neonatal cardiomyocytes does not alter cytosolic free Ca2+ (Hansen et al., 1994).  
Most studies indicate that activation of IP3Rs does not significantly contribute to cardiac E-C 
coupling. A functional role for IP3Rs has been proposed in the pathophysiology of myocardial 
hypertrophy and cardiac arrhythmias. Indeed, IP3Rs have been indirectly implicated in the 
  
 
This article is protected by copyright. All rights reserved. 
  
11 
development of left ventricular hypertrophy via upstream signaling pathways coupled to IP3, 
including α1AR, angiotensin II, and endothelin-1 (Akhter et al., 1998). However, other studies have 
demonstrated a main role for diacylglycerol (the other product resulting from PLC hydrolysis) and 
subsequent PKC activation, more than a direct IP3R activation, in the induction of cardiac 
hypertrophy (Zhang et al., 2013). A significant upregulation of IP3Rs has been reported in patients 
with chronic atrial fibrillation (Yamda et al., 2001). Moreover, increased IP3 levels in the heart have 
been described during early post-ischemic reperfusion following activation of α1 adrenergic 
receptors (α1ARs) or thrombin receptors, correlating with the development of ventricular 
arrhythmias (Mouton et al., 1991).  
 
Intracellular Ca2+ leak and mitochondrial function in HF 
We have recently demonstrated an accumulation of Ca2+ in cardiac mitochondria during HF (Santulli 
et al., 2015b). This mitochondrial Ca2+ overload was mirrored by an increased intracellular Ca2+ leak 
via RyR2 made leaky due to stress induced remodeling and was significantly attenuated when such 
intracellular leak was prevented (Santulli et al., 2015b). Of note, ventricular cardiomyocytes 
harboring constitutively leaky RyR2 channels exhibited both structural and functional mitochondrial 
alterations, with augmented ROS generation and a reduction in mitochondrial ATP content and 
generation (Santulli et al., 2015b). Associated with intracellular Ca2+ leak via RyR2 we detected a 
marked reduction in cristae density, mitochondrial size, aspect ratio, and form factor, indicating a 
low fusion-to-fission ratio (Santulli et al., 2015b). These findings suggest that leaky RyR2 channels 
may lead to increased mitochondrial fragmentation, strongly supporting a functional role for Ca2+ in 
regulating mitochondrial morphological dynamism. To investigate the specific role of IP3R2 in HF, we 
generated a murine model in which IP3R2 expression was specifically ablated via Cre/Lox 
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recombination in ventricular cardiomyocytes (IP3R2VC-/-) (Santulli et al., 2015b). IP3R2VC-/- mice 
survived to adulthood without alterations in baseline myocardial function, and there was no 
significant up-regulation of the other IP3R isoforms (Santulli et al., 2015b). Ca2+ sparks, SR Ca2+ load, 
mitochondrial Ca2+ level, and ROS production were not significantly changed in IP3R2VC-/- ventricular 
cardiomyocytes evaluated both in sham and HF mice (Santulli et al., 2015b). Importantly, myocardial 
mitochondria from IP3R2VC-/- mice were normal, and there was no major effect on HF progression, 
evaluated by serial echocardiography for 4 weeks following ligation of the coronary artery (Santulli et 
al., 2015b). 
These data establish that the intracellular Ca2+ leak via RyR2 - but not IP3R2 - channels plays a role in 
determining mitochondrial Ca2+ overload and dysfunction in HF. Our findings indicate the presence of 
a feedback loop between SR and mitochondria in HF, a vicious cycle that also plays a role in the 
pathophysiology of atrial fibrillation (Xie et al., 2015), in which SR Ca2+ leak triggers mitochondrial 
dysfunction and increases ROS production, which in turn can further oxidize RyR2 and enhance the 
leak, contributing to impaired cardiac function post-MI (Santulli et al., 2015b). 
 
Functional role of endothelial IP3R1 in the regulation of blood pressure 
Calcineurin inhibitors are first line immunosuppressants commonly used in organ transplantation 
(Sharif et al., 2011; Santulli & Totary-Jain, 2013). However, up to 70% of patients under treatment 
calcineurin inhibitors develop arterial hypertension (Moes et al., 2014). We recently demonstrated 
that one of the mechanisms is the impaired production of the vasodilator nitric oxide (NO) by 
vascular EC. To dissect this pathway in detail we generated mice with EC-specific deletion of IP3R1 
(IP3R1EC-/-) (Yuan et al., 2016). EC-specific deletion of IP3R1 led to hypertension, with severely 
impaired arterial relaxation. We also demonstrated that the IP3R1/calcineurin/NFAT/eNOS/NO 
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signaling pathway is less activated in IP3R1EC-/- mice, resulting in reduced eNOS expression and 
activity (Yuan et al., 2016). Moreover, we found that the IP3R1/calcineurin/NFAT/eNOS/NO pathway 
is inhibited by cyclosporine-A and that reduction in IP3R1-mediated NO production likely contributes 
to hypertension associated with calcineurin inhibition (Yuan et al., 2016). Therefore, we provide a 
novel mechanism underlying one of the most important side effects of the leading drugs, calcineurin 
inhibitors, used for immunosuppression following organ transplant, and show that the maintenance 
of normal blood pressure is dependent on IP3R1-mediated regulation of eNOS. The significance of 
these discoveries are two-fold: 1) it places the IP3R1 in a critical signaling pathway regulating 
calcineurin/NFAT nuclear translocation/eNOS/NO; and 2) provide a mechanism underlying 
calcineurin inhibitor induced hypertension (Yuan et al., 2016). 
 
 
Mechanistic role of IP3Rs and RyRs in diabetes mellitus 
Altered intracellular Ca2+ homeostasis is considered a main contributor to impaired pancreatic beta 
cell function in diabetes mellitus. However, according to the classical view of the glucose sensing 
machinery, insulin secretion largely depends on the depolarization of the plasma membrane and the 
subsequent voltage-activated Ca2+ influx from the extracellular milieu (Santulli et al., 2012). The 
mechanistic role of Ca2+ release from the ER in response to glucose has not been fully investigated 
and remains controversial. Moreover, increased expression of IP3R1 and RyR2 has been reported in 
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Mice exhibiting defects in IP3R expression displayed defective insulin release from pancreatic islets 
(Srivastava et al., 1999). PKA-mediated promotion of Ca2+-induced Ca2+ release via IP3Rs has been 
implicated as part of the mechanism by which cAMP amplifies insulin secretion (Chen et al., 2009). 
Moreover, IP3R2/IP3R3 double KO mice are lean and hypoglycemic despite a normal caloric intake, 
most likely as a result of difficulties in nutrient digestion (Futatsugi et al., 2005). Most recently, 
mathematical simulation studies demonstrated that IP3R1 is synergistically activated in beta cells by 
glucose metabolism and the GLP-1/cAMP pathway (Takeda et al., 2016).  
 
RyRs 
The specific expression of RyR2 channels in highly purified pancreatic human beta cells has been 
recently confirmed (Blodgett et al., 2015). Their potential involvement in insulin release had been 
suggested by in vitro experimental data showing an enhanced Ca2+ response in beta cells following 
caffeine treatment (Lemmens et al., 2001). Moreover, calstabin2 KO mice display impaired glucose-
induced insulin secretion (Noguchi et al., 2008). Of interest, both IP3Rs and RyRs have been 
implicated by pharmacological assays in ER stress in pancreatic beta cells (Luciani et al., 2009). We 
recently demonstrated that dysfunction in RyR2 in beta cells leads to ER stress and mitochondrial 
dysfunction, eventually causing impaired insulin secretion. We verified the presence of Ca2+ leak in 
both murine models of diabetes mellitus and in studies in human pancreatic islets from diabetic 
patients (Santulli et al., 2015a). These results have been confirmed by independent groups (Llanos et 
al., 2015; Li et al., 2016), opening a new field of investigation in the diabetes research. 
Summary 
We have provided an overview of the mechanistic roles of the main intracellular Ca2+ release 
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channels, namely RyRs and IP3Rs in health and disease. A growing amount of evidence, examined in 
this review, supports the view that, albeit structurally related, these channels exhibit distinct 
pharmacologic and physiologic profiles. 
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Figure 1. Excitation-contraction coupling in the skeletal muscle. 
Schematic representation of the functional role of Type 1 ryanodine receptor (RyR1) in the 
regulation of excitation-contraction coupling in the skeletal muscle. There is no experimental 
evidence for a role of IP3Rs in this process; moreover, IP3Rs have been more characterized in 
myoblasts than in adult, differentiated cells. AC: Adenylyl cyclase; AR:  adrenergic receptor; cAMP: 
Cyclic adenosine monophosphate; ETC: electron transport chain; Cav1.1: Ca2+ channel, voltage-
dependent, L type, alpha 1S subunit, also known as dihydropyridine receptor; ROS: reactive oxygen 
species; PKA: protein kinase A; SERCA: sarco/endoplasmic reticulum Ca2+-ATPase. 
  
 




Figure 2. Excitation-contraction and calcium signaling coupling in the cardiac muscle. 
Schematic representation of the functional role of intracellular calcium release channels in the 
regulation of calcium signaling and excitation-contraction coupling in the cardiac muscle. AC: 
Adenylyl cyclase; AKT/PKB: protein kinase B; AR:  adrenergic receptor; ETC: electron transport 
chain; Cav1.2: Ca2+ channel, voltage-dependent, L type, alpha 1C subunit; cAMP: Cyclic adenosine 
monophosphate; DAG: diacylglycerol (DAG); ERK: extracellular signal–regulated kinase; GPCR: G 
protein–coupled receptor; IP3 inositol 1,4,5-trisphosphate; IP3R: IP3 inositol 1,4,5-trisphosphate 
receptor; JNK: c-Jun N-terminal kinase; NFAT: Nuclear factor of activated T-cells; PIP2: 
Phosphatidylinositol 4,5-bisphosphate; PKA: protein kinase A; PLC: Phospholipase C; ROS: reactive 
oxygen species; RyR2: Type 2 ryanodine receptor; SERCA: sarco/endoplasmic reticulum Ca2+-ATPase. 
 
